iRadimed
IRMD
67 hedge funds and large institutions have $57.2M invested in iRadimed in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 14 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 22
0.34% more ownership
Funds ownership: 21.05% → 21.38% (+0.34%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 68 → 67 (-1)
32% less capital invested
Capital invested by funds: $83.5M → $57.2M (-$26.3M)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$3.27M |
| 2 |
JP Morgan Chase
New York
|
+$935K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$704K |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$621K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$601K |
Top Sellers
IRMD Hedge Fund Activity: Q4 2018 in Review
67 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2018, worth a combined $57.2M — down 32% from $83.5M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of IRMD and 13 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 23 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.27M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $2.61M sold.
- 67 institutional investors held iRadimed (IRMD) as of Q4 2018, down from 68 in Q3 2018.
- Funds reported $57.2M of iRadimed stock for Q4 2018, down 32% quarter-over-quarter.
- 13 funds opened new iRadimed positions in Q4 2018 and 14 closed out, a net change of -1 holder.
- The largest iRadimed buyer in Q4 2018 was Renaissance Technologies, an estimated $3.27M added.
- The largest iRadimed seller in Q4 2018 was Driehaus Capital Management, an estimated $2.61M sold.
Based on aggregated 13F filings for Q4 2018.